Browse Pet Safety Reports
16,709 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,709 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,709 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Jun 4, 2019 | Human | Unknown | Afoxolaner | Tingling sensation; Accidental exposure | Outcome Unknown |
| Jun 3, 2019 | Human | Unknown | Fluralaner Chew Tablets | Allergic reaction; Burning sensation (skin); Nasal irritation; Nasal congesti... | Ongoing |
| Jun 3, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| Jun 1, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error; Difficulty of Use | Recovered/Normal |
| Jun 1, 2019 | Human | Unknown | Amoxicillin Trihydrate;Clavulanate Po... | Burning sensation (skin) | Recovered/Normal |
| May 31, 2019 | Human | Unknown | Maropitant Citrate | Pain NOS; Puncture wound | Ongoing |
| May 31, 2019 | Human | Unknown | Selamectin | Headache; Bad taste; Throat pain | Outcome Unknown |
| May 31, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Tingling skin | Recovered/Normal |
| May 30, 2019 | Human | Unknown | Pyrantel Pamoate; Praziquantel | Eye irritation; Accidental exposure | Outcome Unknown |
| May 28, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site burning sensation; Application site reddening; Odor, Abnorma... | Outcome Unknown |
| May 28, 2019 | Human | Unknown | Enrofloxacin | Injection site lesion | Outcome Unknown |
| May 28, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Application site tingling; Pruritus | Recovered/Normal |
| May 27, 2019 | Human | Unknown | Milbemycin Oxime; Praziquantel | Bad taste; Accidental exposure; No sign | Recovered/Normal |
| May 24, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site skin change NOS; Containers, Leaking; Diff... | Ongoing |
| May 24, 2019 | Human | Unknown | Eprinomectin | Injection site pain | Recovered/Normal |
| May 24, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site hair loss | Ongoing |
| May 24, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Bad taste; Accidental exposure | Recovered/Normal |
| May 23, 2019 | Human | Unknown | Spinosad; Milbemycin Oxime | Nausea | Recovered/Normal |
| May 23, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site skin change NOS; Containers, Leaking; Diff... | Ongoing |
| May 22, 2019 | Human | Unknown | Tulathromycin | Injection site pain; Injection site swelling; Puncture wound | Outcome Unknown |
| May 22, 2019 | Human | Unknown | Selamectin | Headache; Pain NOS; Fever; Hypothermia; Diarrhoea | Outcome Unknown |
| May 22, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error; Difficulty of Use; Dispen... | Ongoing |
| May 21, 2019 | Human | Unknown | Nitenpyram | Chest discomfort NOS | Recovered/Normal |
| May 21, 2019 | Human | Unknown | Selamectin | Bad taste | Recovered/Normal |
| May 21, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Medication error; Difficulty of Use; Dispen... | Ongoing |
| May 20, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| May 20, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS | Recovered/Normal |
| May 19, 2019 | Human | Unknown | Tilmicosin | Abdominal cramp; Diarrhoea; Constipation; Difficulty in micturition; Accident... | Recovered/Normal |
| May 18, 2019 | Human | Unknown | Pyrantel Pamoate; Praziquantel | Nausea | Outcome Unknown |
| May 17, 2019 | Human | Unknown | Grapiprant | Blistering (see also Application site SOC) | Outcome Unknown |
| May 16, 2019 | Human | Unknown | Tiletamine Hcl, Zolazepam Hcl | Injection site reddening; Medication error | Outcome Unknown |
| May 16, 2019 | Human | Unknown | Meloxicam | Sore eye | Outcome Unknown |
| May 16, 2019 | Human | Unknown | Bupivacaine Lipsome Injectable Suspen... | Dry eye | Outcome Unknown |
| May 15, 2019 | Human | Unknown | Selamectin;Sarolaner | Skin irritation | Recovered/Normal |
| May 15, 2019 | Human | Unknown | Spinosad | Nervousness; Nausea | Recovered/Normal |
| May 14, 2019 | Human | Unknown | Doramectin | Injection site pain; Injection site swelling | Outcome Unknown |
| May 13, 2019 | Human | Unknown | Selamectin | Eye irritation; Bad taste; Accidental exposure | Outcome Unknown |
| May 13, 2019 | Human | Unknown | Tilmicosin | Injection site tingling; Accidental exposure | Outcome Unknown |
| May 12, 2019 | Human | Unknown | Vit E/ Selenite Inj Solution | Injection site bleeding; Stinging skin; Injection site reaction NOS | Outcome Unknown |
| May 11, 2019 | Human | Unknown | Moxidectin | Diarrhoea | Outcome Unknown |
| May 10, 2019 | Human | Unknown | Imidacloprid; Moxidectin | Eye irritation | Outcome Unknown |
| May 9, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Localised numbness (see also application site SOC); General illness; Medicati... | Recovered/Normal |
| May 9, 2019 | Human | Unknown | Mirtazapine | Local swelling (not application site) | Recovered/Normal |
| May 8, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Application site skin change NOS; Containers, Leaking; Dispenser, Abnormal | Recovered/Normal |
| May 8, 2019 | Human | Unknown | Flunixin Megl Topical Solution | Application site reddening; Application site swelling; Application site scar;... | Ongoing |
| May 7, 2019 | Human | Unknown | Tulathromycin | Injection site swelling | Outcome Unknown |
| May 6, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Facial rash (For urticaria see Immune SOC); Pimples | Ongoing |
| May 6, 2019 | Human | Unknown | Orbifloxacin Oral Suspension | Application site skin change NOS; Defect Unknown/Not Specified | Recovered/Normal |
| May 5, 2019 | Human | Unknown | Moxidectin | Nausea; Retching; Headache; Fatigue; Increased sweating | Recovered/Normal |
| May 5, 2019 | Human | Unknown | Fluralaner Spot-On Solution | Product problem; Application site skin change NOS; Containers, Leaking; Accid... | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.